Spagnolo P, Kimes A, Schwandt M, Shokri-Kojori E, Thada S, Phillips K
Biol Psychiatry. 2019; 86(5):356-364.
PMID: 31097294
PMC: 6699765.
DOI: 10.1016/j.biopsych.2019.03.965.
de Oliveira Guaita G, Vecchia D, Andreatini R, Robinson D, Schwarting R, da Cunha C
Psychopharmacology (Berl). 2018; 235(7):1887-1896.
PMID: 29572651
DOI: 10.1007/s00213-018-4878-8.
Brown R, Kirby S, Denton A, Dose J, Cummins E, Drew Gill W
Schizophr Res. 2017; 194:107-114.
PMID: 28314679
PMC: 5599315.
DOI: 10.1016/j.schres.2017.03.024.
Sustkova-Fiserova M, Jerabek P, Havlickova T, Syslova K, Kacer P
Psychopharmacology (Berl). 2015; 233(3):469-84.
PMID: 26507196
DOI: 10.1007/s00213-015-4119-3.
Puglisi-Allegra S, Ventura R
Front Behav Neurosci. 2012; 6:31.
PMID: 22754514
PMC: 3384081.
DOI: 10.3389/fnbeh.2012.00031.
Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1.
Achat-Mendes C, Lynch L, Sullivan K, Vallender E, Miller G
Pharmacol Biochem Behav. 2011; 101(2):201-7.
PMID: 22079347
PMC: 3288391.
DOI: 10.1016/j.pbb.2011.10.025.
Opiate versus psychostimulant addiction: the differences do matter.
Badiani A, Belin D, Epstein D, Calu D, Shaham Y
Nat Rev Neurosci. 2011; 12(11):685-700.
PMID: 21971065
PMC: 3721140.
DOI: 10.1038/nrn3104.
Dissociable roles of mGlu5 and dopamine receptors in the rewarding and sensitizing properties of morphine and cocaine.
Veeneman M, Boleij H, Broekhoven M, Snoeren E, Guitart Masip M, Cousijn J
Psychopharmacology (Berl). 2010; 214(4):863-76.
PMID: 21120457
PMC: 3063544.
DOI: 10.1007/s00213-010-2095-1.
Loss of cocaine locomotor response in Pitx3-deficient mice lacking a nigrostriatal pathway.
Beeler J, Huang Cao Z, Kheirbek M, Zhuang X
Neuropsychopharmacology. 2008; 34(5):1149-61.
PMID: 18704092
PMC: 2752723.
DOI: 10.1038/npp.2008.117.
Morphine-conditioned single-trial place preference: role of nucleus accumbens shell dopamine receptors in acquisition, but not expression.
Fenu S, Spina L, Rivas E, Longoni R, Di Chiara G
Psychopharmacology (Berl). 2006; 187(2):143-53.
PMID: 16724186
DOI: 10.1007/s00213-006-0415-2.
Dopamine D3 receptor ligands modulate the acquisition of morphine-conditioned place preference.
Frances H, Smirnova M, Leriche L, Sokoloff P
Psychopharmacology (Berl). 2004; 175(2):127-33.
PMID: 15095031
DOI: 10.1007/s00213-004-1807-9.
Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core.
Sellings L, Clarke P
J Neurosci. 2003; 23(15):6295-303.
PMID: 12867514
PMC: 6740552.
Increased rewarding properties of morphine in dopamine-transporter knockout mice.
Spielewoy C, Gonon F, Roubert C, Fauchey V, Jaber M, Caron M
Eur J Neurosci. 2000; 12(5):1827-37.
PMID: 10792459
PMC: 1904481.
DOI: 10.1046/j.1460-9568.2000.00063.x.
Electrophysiological characterization of GABAergic neurons in the ventral tegmental area.
Steffensen S, Svingos A, Pickel V, Henriksen S
J Neurosci. 1998; 18(19):8003-15.
PMID: 9742167
PMC: 6793009.
Effects of haloperidol in a response-reinstatement model of heroin relapse.
Ettenberg A, MacConell L, Geist T
Psychopharmacology (Berl). 1996; 124(3):205-10.
PMID: 8740040
DOI: 10.1007/BF02246658.
Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats.
Guyon A, Assouly-Besse F, Biala G, Puech A, Thiebot M
Psychopharmacology (Berl). 1993; 110(4):460-6.
PMID: 7870917
DOI: 10.1007/BF02244653.
Lack of evidence for an involvement of nucleus accumbens dopamine D1 receptors in the initiation of heroin self-administration in the rat.
Gerrits M, Ramsey N, Wolterink G, van Ree J
Psychopharmacology (Berl). 1994; 114(3):486-94.
PMID: 7855207
DOI: 10.1007/BF02249340.
Fentanyl-induced conditional place preference: lack of associated conditional neurochemical events.
FINLAY J, JAKUBOVIC A, Phillips A, Fibiger H
Psychopharmacology (Berl). 1988; 96(4):534-40.
PMID: 3149777
DOI: 10.1007/BF02180036.
Cocaine-induced place conditioning: importance of route of administration and other procedural variables.
Nomikos G, Spyraki C
Psychopharmacology (Berl). 1988; 94(1):119-25.
PMID: 3126520
DOI: 10.1007/BF00735892.
Facilitation of latent inhibition by haloperidol in rats.
Weiner I, Feldon J
Psychopharmacology (Berl). 1987; 91(2):248-53.
PMID: 3107041
DOI: 10.1007/BF00217073.